Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eledon Pharmaceuticals (ELDN) Preferred Shares (2016)

Eledon Pharmaceuticals filings provide 1 years of Preferred Shares readings, the most recent being $19000.0 for Q4 2016.

  • On a quarterly basis, Preferred Shares changed N/A to $19000.0 in Q4 2016 year-over-year; TTM through Dec 2016 was $19000.0, a N/A change, with the full-year FY2016 number at $19000.0, changed N/A from a year prior.
  • Preferred Shares hit $19000.0 in Q4 2016 for Eledon Pharmaceuticals.
  • In the past five years, Preferred Shares ranged from a high of $19000.0 in Q4 2016 to a low of $19000.0 in Q4 2016.